| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5675719 | American Journal of Obstetrics and Gynecology | 2017 | 29 Pages |
Abstract
Compared to women taking aromatase inhibitors, gynecologic symptoms, procedures, and pathology are higher for both premenopausal and postmenopausal women with breast cancer on tamoxifen. Increased efforts to curb use of gynecologic interventions in asymptomatic women are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jason D. MD, Vrunda B. MD, Ling MD, MPH, William M. MD, Ana I. MD, June Y. MD, Melissa MD, Cande V. PhD, MPH, Alfred I. MD, PhD, Dawn L. MD,